Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
Authors:
Top Cited Papers
Open Access
- 1 January 2017
- journal article
- review article
- Published by Japan Academy in Proceedings of the Japan Academy, Series B
- Vol. 93 (7) , 449-463
Abstract
Favipiravir (T-705; 6-fluoro-3-hydroxy-2-pyrazinecarboxamide) is an anti-viral agent that selectively and potently inhibits the RNA-dependent RNA polymerase (RdRp) of RNA viruses. Favipiravir was discovered through screening chemical library for anti-viral activity against the influenza virus by Toyama Chemical Co., Ltd. Favipiravir undergoes an intracellular phosphoribosylation to be an active form, favipiravir-RTP (favipiravir ribofuranosyl-5'-triphosphate), which is recognized as a substrate by RdRp, and inhibits the RNA polymerase activity. Since the catalytic domain of RdRp is conserved among various types of RNA viruses, this mechanism of action underpins a broader spectrum of anti-viral activities of favipiravir. Favipiravir is effective against a wide range of types and subtypes of influenza viruses, including strains resistant to existing anti-influenza drugs. Of note is that favipiravir shows anti-viral activities against other RNA viruses such as arenaviruses, bunyaviruses and filoviruses, all of which are known to cause fatal hemorrhagic fever. These unique anti-viral profiles will make favipiravir a potentially promising drug for specifically untreatable RNA viral infections.Keywords
This publication has 58 references indexed in Scilit:
- Dose regimen of favipiravir for Ebola virus diseaseThe Lancet Infectious Diseases, 2015
- Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviralJournal of Antimicrobial Chemotherapy, 2014
- Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatmentAntiviral Research, 2014
- Post-exposure efficacy of Oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse modelAntiviral Research, 2014
- The First Identification and Retrospective Study of Severe Fever With Thrombocytopenia Syndrome in JapanThe Journal of Infectious Diseases, 2013
- Global alert to avian influenza virus infection: From H5N1 to H7N9Pathogens and Global Health, 2013
- Effects of the Combination of Favipiravir (T-705) and Oseltamivir on Influenza A Virus Infections in MiceAntimicrobial Agents and Chemotherapy, 2010
- T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infectionsAntiviral Research, 2009
- In Vitroandin VivoActivities of T-705 and Oseltamivir against Influenza VirusAntiviral Chemistry and Chemotherapy, 2003
- Ribavirin's antiviral mechanism of action: lethal mutagenesis?Journal of Molecular Medicine, 2002